DK189584D0 - (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse - Google Patents

(5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse

Info

Publication number: DK189584D0
Authority: DK; Denmark
Prior art keywords: 5alfa; spirox; oner; preparation
Prior art date: 1983-04-13

Application number

DK1895/84A

Other languages

English (en)

Other versions

DK189584A (da

Inventor

Juergen Grob

Jaroslav Kalvoda

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-04-13

Filing date

1984-04-12

Publication date

1984-04-12

1984-04-12 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1984-04-12 Publication of DK189584D0 publication Critical patent/DK189584D0/da

1984-10-14 Publication of DK189584A publication Critical patent/DK189584A/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK189584A 1983-04-13 1984-04-12 (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse DK189584A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH197983		1983-04-13
CH197983		1983-04-13

Publications (2)

Publication Number	Publication Date
DK189584D0 true DK189584D0 (da)	1984-04-12
DK189584A DK189584A (da)	1984-10-14

Family

ID=4223075

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK189584A DK189584A (da)	1983-04-13	1984-04-12	(5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse

Country Status (6)

Country	Link
US (1)	US4552871A (da)
EP (1)	EP0122882A1 (da)
JP (1)	JPS59205400A (da)
AU (1)	AU2685284A (da)
DK (1)	DK189584A (da)
ES (1)	ES531516A0 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999061055A1 (en)	1998-05-22	1999-12-02	The Board Of Trustees Of The Leland Stanford Junior University	Bifunctional molecules and therapies based thereon
CA2469616A1 (en)	2001-12-12	2003-06-19	James W. Aiken	Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
CA2789097C (en)	2005-04-28	2017-02-21	Proteus Digital Health, Inc.	Pharma-informatics system
WO2007035716A2 (en)	2005-09-16	2007-03-29	Raptor Pharmaceutical Inc.	Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
NZ616673A (en)	2009-02-20	2014-08-29	To Bbb Holding B V	Glutathione-based drug delivery system
ES2942923T3 (es)	2009-05-06	2023-06-07	Laboratory Skin Care Inc	Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3095412A (en) *	1961-12-19	1963-06-25	Searle & Co	9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1368731A (en) *	1972-01-24	1974-10-02	Searle & Co	9alpha 11alpha-epoxy spirolactones and corresponding spirolactols and lactol ethers
CH631462A5 (de) *	1976-03-05	1982-08-13	Schering Ag	Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
US4079054A (en) *	1976-12-22	1978-03-14	Schering Corporation	7α-Halogeno-3-oxo-1,4-pregnadiene-21,17β-carbolactones and related compounds

1984
- 1984-04-09 US US06/598,132 patent/US4552871A/en not_active Expired - Fee Related
- 1984-04-10 EP EP84810178A patent/EP0122882A1/de not_active Withdrawn
- 1984-04-11 ES ES531516A patent/ES531516A0/es active Granted
- 1984-04-12 AU AU26852/84A patent/AU2685284A/en not_active Abandoned
- 1984-04-12 JP JP59071899A patent/JPS59205400A/ja active Pending
- 1984-04-12 DK DK189584A patent/DK189584A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0122882A1 (de)	1984-10-24
US4552871A (en)	1985-11-12
JPS59205400A (ja)	1984-11-20
ES8602845A1 (es)	1985-12-01
AU2685284A (en)	1984-10-18
ES531516A0 (es)	1985-12-01
DK189584A (da)	1984-10-14

Similar Documents

Publication	Publication Date	Title
DK41484A (da)	1984-08-01	Beta-phenethanolaminer og deres anvendelse
DK559985D0 (da)	1985-12-03	13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK554784A (da)	1985-05-24	Substituerede 5-amino-4-hydroxyvalerylderivater samt deres fremstilling og anvendelse
DK578185D0 (da)	1985-12-13	13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK420785D0 (da)	1985-09-17	13-halogen- eller 13-hydroxymilbemyciner samt deres fremstilling og anvendelse
DK35884A (da)	1984-07-28	Lactampeptider samt deres fremstilling og anvendelse
DK614084A (da)	1985-07-01	Milbemycim-derivater samt deres fremstilling og anvendelse
DK614384D0 (da)	1984-12-20	Substituerede imidazoler samt deres fremstilling og anvendelse
DK294684D0 (da)	1984-06-15	N-alkylerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK537785D0 (da)	1985-11-21	Flavolignanderivater samt deres fremstilling og anvendelse
DK558484A (da)	1985-05-26	Milbemycinderivater samt deres fremstilling og anvendelse
DK189584D0 (da)	1984-04-12	(5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse
DK419084D0 (da)	1984-08-31	2-aminomethyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK393285A (da)	1986-03-01	Substituerede carbonylphenylsulfonylguanidiner samt deres fremstilling og anvendelse
DK236585D0 (da)	1985-05-28	Acylerede hexosederivater samt deres fremstilling og anvendelse
DK358882A (da)	1983-02-12	Anthracyclinantibiotica samt deres fremstilling og anvendelse
DK35984A (da)	1984-07-28	Lactampeptider samt deres fremstilling og anvendelse
DK522883D0 (da)	1983-11-15	2-heterocyclythio-alkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK613984D0 (da)	1984-12-20	2-heterocyclyl-6-hydroxylavalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK422685D0 (da)	1985-09-18	Benzazolderivater samt deres fremstilling og anvendelse
DK162607C (da)	1992-05-11	Azopigmentpraeparater og deres anvendelse
DK153285D0 (da)	1985-04-03	Benzodioxolderivater samt deres fremstilling og anvendelse
DK361185A (da)	1986-02-10	2-aminoalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK381784A (da)	1985-02-10	Acylerede hydrazinforbindelser samt deres fremstilling og anvendelse
DK174684D0 (da)	1984-03-30	7beta-acylamido-3-cephem-4-carboxylsyreforbindelser samt deres fremstilling og anvendelse

Legal Events

Date	Code	Title	Description
1987-12-14	AHB	Application shelved due to non-payment
1990-07-09	AHS	Application shelved for other reasons than non-payment